Ayr Wellness FY2024 EPS Estimate Decreased by Roth Capital

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Research analysts at Roth Capital lowered their FY2024 earnings estimates for Ayr Wellness in a report released on Wednesday, November 13th. Roth Capital analyst W. Kirk now forecasts that the company will earn ($1.40) per share for the year, down from their prior estimate of ($1.22). Roth Capital has a “Strong-Buy” rating on the stock. The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.30) per share. Roth Capital also issued estimates for Ayr Wellness’ Q4 2024 earnings at ($0.34) EPS, Q1 2025 earnings at ($0.32) EPS, Q2 2025 earnings at ($0.31) EPS, Q3 2025 earnings at ($0.30) EPS, Q4 2025 earnings at ($0.30) EPS and FY2025 earnings at ($1.23) EPS.

Other equities analysts have also recently issued research reports about the company. Roth Mkm reduced their price target on Ayr Wellness from $3.50 to $3.00 and set a “buy” rating for the company in a report on Thursday. Atb Cap Markets lowered shares of Ayr Wellness from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 13th.

Ayr Wellness Trading Down 1.3 %

Shares of Ayr Wellness stock opened at $0.77 on Monday. Ayr Wellness has a fifty-two week low of $0.71 and a fifty-two week high of $4.09. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.67 and a current ratio of 1.59. The company has a market cap of $87.90 million, a P/E ratio of -0.35 and a beta of 2.00. The firm has a 50-day simple moving average of $1.82 and a two-hundred day simple moving average of $1.98.

Ayr Wellness Company Profile

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.